These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24980279)

  • 1. Evaluating protocol lifecycle time intervals in HIV/AIDS clinical trials.
    Rosas SR; Schouten JT; Dixon D; Varghese S; Cope MT; Marci J; Kagan JM
    Clin Trials; 2014 Oct; 11(5):553-9. PubMed ID: 24980279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.
    Carlson RW; Tu SW; Lane NM; Lai TL; Kemper CA; Musen MA; Shortliffe EH
    Online J Curr Clin Trials; 1995 Mar; Doc No 179():[3347 words; 32 paragraphs]. PubMed ID: 7719564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the challenges of multi-scope clinical research sites: an example from NIH HIV/AIDS clinical trials networks.
    Rosas SR; Cope MT; Villa C; Motevalli M; Utech J; Schouten JT
    J Eval Clin Pract; 2014 Apr; 20(2):149-57. PubMed ID: 24219425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and implementation of clinical trial protocol templates at the National Institute of Allergy and Infectious Diseases.
    Bridge H; Smolskis M; Bianchine P; Dixon DO; Kelly G; Herpin B; Tavel J;
    Clin Trials; 2009 Aug; 6(4):386-91. PubMed ID: 19625326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a checklist of quality indicators for clinical trials in resource-limited countries: the French National Agency for Research on AIDS and Viral Hepatitis (ANRS) experience.
    Hanna M; Minga A; Fao P; Borand L; Diouf A; Mben JM; Gad RR; Anglaret X; Bazin B; Chene G;
    Clin Trials; 2013 Apr; 10(2):300-18. PubMed ID: 23345311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing the effectiveness of a motivational interviewing-based brief intervention for substance use as an adjunct to usual care in community-based AIDS service organizations: study protocol for a multisite randomized controlled trial.
    Garner BR; Gotham HJ; Tueller SJ; Ball EL; Kaiser D; Stilen P; Speck K; Vandersloot D; Rieckmann TR; Chaple M; Martin EG; Martino S
    Addict Sci Clin Pract; 2017 Nov; 12(1):31. PubMed ID: 29149914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implementation of a continuum of care for people living with HIV/AIDS in Hanoi (Vietnam)].
    de Loenzien M
    Sante; 2009; 19(3):141-8. PubMed ID: 20185390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions.
    Angelidou K; Fowler MG; Flynn P; Coletti A; McCarthy K; Browning R; McIntyre J; Brummel SS; Shapiro DE; Tierney C;
    Clin Trials; 2020 Aug; 17(4):437-447. PubMed ID: 32191142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NIAID Division of AIDS enterprise information system: integrated decision support for global clinical research programs.
    Kagan JM; Gupta N; Varghese S; Virkar H
    J Am Med Inform Assoc; 2011 Dec; 18 Suppl 1(Suppl 1):i161-5. PubMed ID: 21816958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focusing National Institutes of Health HIV/AIDS research for maximum population impact.
    Walensky RP; Auerbach JD;
    Clin Infect Dis; 2015 Mar; 60(6):937-40. PubMed ID: 25422391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrollment of racial/ethnic minorities in NIAID-funded networks of HIV vaccine trials in the United States, 1988 to 2002.
    Djomand G; Katzman J; di Tommaso D; Hudgens MG; Counts GW; Koblin BA; Sullivan PS
    Public Health Rep; 2005; 120(5):543-8. PubMed ID: 16224987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group.
    Rosendorf LL; Dafni U; Amato DA; Lunghofer B; Bartlett JG; Leedom JM; Wara DW; Armstrong JA; Godfrey E; Sukkestad E
    Control Clin Trials; 1993 Dec; 14(6):523-37. PubMed ID: 8119067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scientific and social issues of human immunodeficiency virus vaccine development.
    Haynes BF
    Science; 1993 May; 260(5112):1279-86. PubMed ID: 8493572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
    Volberding PA; Lagakos SW; Grimes JM; Stein DS; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS; Phair JP; Mitsuyasu RT
    JAMA; 1994 Aug; 272(6):437-42. PubMed ID: 7913730
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.